CIPLA
Back to Cashflow Statement
|
CIPLA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1,200 Cr | ₹-958 Cr | ₹-1,600 Cr | ₹-1,240 Cr | ₹-2,949 Cr |
What is the latest Cash Flow from Financing Activities ratio of CIPLA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-1,200 Cr |
Mar2023 | ₹-958 Cr |
Mar2022 | ₹-1,600 Cr |
Mar2021 | ₹-1,240 Cr |
Mar2020 | ₹-2,949 Cr |
How is Cash Flow from Financing Activities of CIPLA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-1,200 Cr | Negative | |
Mar2023 | ₹-958 Cr | Negative | |
Mar2022 | ₹-1,600 Cr | Negative | |
Mar2021 | ₹-1,240 Cr | Negative | |
Mar2020 | ₹-2,949 Cr | - |
Compare Cash Flow from Financing Activities of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹121,437.7 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,066.0 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics | |
MANKIND PHARMA | ₹97,090.3 Cr | -1.1% | -8.1% | 6.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -1.2% |
0.8% |
-0.9% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses